Method of inhibiting cancer growth

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 3,10-dihydroxy-2-naphthacene carboxamide or derivative doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514153, 514154, A01N 3718, A61K 3165

Patent

active

058376968

ABSTRACT:
The invention is a method of inhibiting cancer growth, including cellular proliferation, invasiveness, or metastasis in mammals. The method employs 6-demethyl-6-deoxy-4-dedimethylaminotetracycline (CMT-3) and other functionally related chemically modified, preferably non-antibacterial, tetracycline compounds to inhibit cancer growth. The method is particularly effective to inhibit the establishment, growth, and metastasis of solid tumors, such as tumors derived from colon cancer cells, breast cancer cells, melanoma cells, prostatic carcinoma cells, or lung cancer cells.

REFERENCES:
patent: 5308839 (1994-05-01), Golub et al.
patent: 5321017 (1994-06-01), Golub et al.
patent: 5563130 (1996-10-01), Backer
patent: 5567693 (1996-10-01), Backer et al.
patent: 5574026 (1996-11-01), Backer et al.
patent: 5668122 (1997-09-01), Fife et al.
Bassett P, Okada A, Chenard M-P, Kannan R, Stoll I, Anglard P, Bellocq J-P, Rio M-C, "Matrix Metalloproteinases as Stromal Effectors of Human Carcinoma Progression: Therapeutic Implications", Matrix Biology 15:535-541 (1997).
Golub LM, Ramamurthy NS, Leungt M, McNamara TF, "Low-Dose Doxycycline Thrapy: Effect on Gingival and Crevicular Fluid Collagenase Activity in Humans", J. Periodont Res 25:321-330 (1990).
Golub LM, Lee HM, Lehrer G, Nemiroff A, McNamara TF, Kaplan R, Ramamurthy NS, "Minocycline Reduces Gingival Collagenolytic Activity During Diagetes", Journal of Periodontal Research 18:516-526 (1983).
Hatsu M, Sasaki T, Watabe H-O, Miyadoh S, Nagasawa M, Shomura T, Sezaki M, Inouye S, Kondo S, "A New Tetracycline Antibiotic with Antitumor Activity", The Journal of Antibiotics 45(3):320-324 (1992).
Hatsu M, Sasaki T, Gomi S, Kodama Y, Sezaki M, Inouye S, Kondo S, "A New Tetracycline Antibiotic with Antitumor Activity", The Journal of Antibiotics 45(3):325-330 (1992).
Johnson RK, Goldin A, "The Clinical Impact of Screening and Other Experimental Tumor Studies", Cancer Treatment Reviews 2:1-31 (1975).
Okada A, Bellocq J-P, Rouyer N, Chenard M-P, Rio M-C, Chambon P, Basset P, "Membrane-Type Matrix Metalloproteinase (MT-MMP) Gene is Expressed in Stromal Cells of Human Colon, Breast, and Head and Neck Carcinoma", Proc. Natl. Acad. Sci. USA 92:2730-2734 (1995).
Okada A, Tomasetto C, Lutz Y, Bellocq J-P, Rio M-C, Basset P, "Expression of Matrix Metalloproteinases During Rat Skin Wound Healing: Evidence that Membrane Type-1 Matrix Metalloproteinase is a Stromal Activator of Pro-Gelatinase A", The Journal of Cell Biology 137(1):67-77 (1997).
Sotomayor EA, Teicher BA, Schwartz GN, Holden SA, Menon K, Herman TS, Frei III E, Minocycline in Combination with Chemotherapy or Radiation Therapy in Vitro and in Vivo, Cancer Chemother Pharmacol 30:377-384 (1992).
Uitto V-J, Firth JD, Nip L, Golub LM "Doxycycline and Chemically Modified Tetracyclines Inhibit Gelatinase A (MMP-2) Gene Expression in Human Skin Keratinocytes", Annals of the New York Academy of Sciences 732:140-151 (1994).
Zeng ZS, Huang Y, Cohen AM, Guillem JG, "Prediction of Colorectal Cancer Relapse and Survival via Tissue RNA Levels of Matrix Metalloproteinase-9", Journal of Clinical Oncology 14(12):3133-3140 (1996).
Zucker S. Lysik RM, Ramamurthy NS, Golub LM, Wieman JM, Wilkie DP, "Diversity of Melanoma Plasma Membrane Proteinases: Inhibition of Collagenolytic and Cytolytic Activities by Minocycline", JNCI 75(3):517-525 (1985).
Zucker S, Turpeenniemi-Hujanen, T, Ramamurthy N, Wieman J, Lysik R, Gorevic P, Liotta LA, Simon SR, Golub LB, "Purification and Characterization of a Connective-Tissue-Degrading Metalloproteinase from the Cytosol of Metastatic Melanoma Cells", Biochem. J 245:429-437 (1987).
Zucker S, Weiman J, Lysik RM, Imhof B, Nagase H, Ramamurthy N, Liotta LA, Golub LM, "Gelatin-Degrading Type IV Collagenase Isolated from Human Small Cell Lung Cancer", Invasion Metastasis 9:167-181 (1989).
Johnson et al, Cancer Treatment Reviews vol. 2 p. 1, 1975.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Method of inhibiting cancer growth does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of inhibiting cancer growth, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of inhibiting cancer growth will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-884589

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.